Atara Biotherapeutics (ATRA) EBITDA Margin (2021 - 2026)
Atara Biotherapeutics (ATRA) posted EBITDA Margin of -746.98% for Q2 2026, down 766.52 percentage points from 19.53% a year earlier and down 99.70 percentage points from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBITDA Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Atara Biotherapeutics was -227.61%, down 234.18 percentage points year-over-year; for FY2025, it was 31.45%, up 92.24 percentage points from FY2024.
- Annual EBITDA Margin shows a four-year change of +1659.36 percentage points (FY2021 to FY2025).
- In prior years, Atara Biotherapeutics' EBITDA Margin was -60.79% in FY2024 (+3102.36 pp), -3163.15% in FY2023 (-2730.98 pp), -432.17% in FY2022 (+1195.74 pp) and -1627.91% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q4 2023.
- On a year-over-year basis, EBITDA Margin has declined in each of the last four quarters, with an average year-over-year change of +386.88 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2023, with a gain of 28571.36 percentage points; the weakest was Q4 2022, with a drop of 28748.16 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -647.29% (Q1 2026), -157.62% (Q4 2025) and -102.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | -746.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -746.98% |
| Mar 31, 2026 | -647.29% |
| Dec 31, 2025 | -157.62% |
| Sep 30, 2025 | -102.46% |
| Jun 30, 2025 | 19.53% |
| Mar 31, 2025 | 41.36% |
| Dec 31, 2024 | -33.90% |
| Sep 30, 2024 | -51.07% |
| Jun 30, 2024 | -59.01% |
| Mar 31, 2024 | -109.13% |
| Dec 31, 2023 | -1,381.87% |
| Sep 30, 2023 | -3,199.39% |
| Jun 30, 2023 | -7,336.78% |
| Mar 31, 2023 | -6,019.90% |
| Dec 31, 2022 | -29,953.23% |
| Sep 30, 2022 | -1,866.38% |
| Jun 30, 2022 | -59.58% |
| Mar 31, 2022 | -1,184.43% |
| Dec 31, 2021 | -1,205.06% |
| Sep 30, 2021 | -1,536.54% |
API Access
Atara Biotherapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();